Details
Stereochemistry | ACHIRAL |
Molecular Formula | C24H28N4O4 |
Molecular Weight | 436.5035 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(=CC=C1)C(=O)NC2=CC=C(OCCN3CCOCC3)C(=C2)C4=CC=NN4C
InChI
InChIKey=ZEOQUKRCASTCFR-UHFFFAOYSA-N
InChI=1S/C24H28N4O4/c1-27-22(8-9-25-27)21-17-19(26-24(29)18-4-3-5-20(16-18)30-2)6-7-23(21)32-15-12-28-10-13-31-14-11-28/h3-9,16-17H,10-15H2,1-2H3,(H,26,29)
Molecular Formula | C24H28N4O4 |
Molecular Weight | 436.5035 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Temanogrel (also known as APD791) is an oral small molecule inverse agonist of the serotonin 2A (5-HT2A) receptor with potent activity on platelets and vascular smooth muscle. Temanogrel has been studied in phase I clinical trials in healthy subjects to assess its pharmacokinetics, pharmacodynamics, and safety. However, these studies were terminated because of the sponsor’s decision.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL224 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19628629 |
PubMed
Title | Date | PubMed |
---|---|---|
Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosis. | 2010 Jun 10 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT02419820
APD791 (temanogrel) (10 or 20 or 40) mg single dose
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:47:07 GMT 2023
by
admin
on
Fri Dec 15 17:47:07 GMT 2023
|
Record UNII |
F42Z27575A
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66885
Created by
admin on Fri Dec 15 17:47:07 GMT 2023 , Edited by admin on Fri Dec 15 17:47:07 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C544126
Created by
admin on Fri Dec 15 17:47:07 GMT 2023 , Edited by admin on Fri Dec 15 17:47:07 GMT 2023
|
PRIMARY | |||
|
CHEMBL1084617
Created by
admin on Fri Dec 15 17:47:07 GMT 2023 , Edited by admin on Fri Dec 15 17:47:07 GMT 2023
|
PRIMARY | |||
|
300000028173
Created by
admin on Fri Dec 15 17:47:07 GMT 2023 , Edited by admin on Fri Dec 15 17:47:07 GMT 2023
|
PRIMARY | |||
|
C96894
Created by
admin on Fri Dec 15 17:47:07 GMT 2023 , Edited by admin on Fri Dec 15 17:47:07 GMT 2023
|
PRIMARY | |||
|
WW-02
Created by
admin on Fri Dec 15 17:47:07 GMT 2023 , Edited by admin on Fri Dec 15 17:47:07 GMT 2023
|
PRIMARY | |||
|
DTXSID70237321
Created by
admin on Fri Dec 15 17:47:07 GMT 2023 , Edited by admin on Fri Dec 15 17:47:07 GMT 2023
|
PRIMARY | |||
|
DB05227
Created by
admin on Fri Dec 15 17:47:07 GMT 2023 , Edited by admin on Fri Dec 15 17:47:07 GMT 2023
|
PRIMARY | |||
|
9285
Created by
admin on Fri Dec 15 17:47:07 GMT 2023 , Edited by admin on Fri Dec 15 17:47:07 GMT 2023
|
PRIMARY | |||
|
F42Z27575A
Created by
admin on Fri Dec 15 17:47:07 GMT 2023 , Edited by admin on Fri Dec 15 17:47:07 GMT 2023
|
PRIMARY | |||
|
887936-68-7
Created by
admin on Fri Dec 15 17:47:07 GMT 2023 , Edited by admin on Fri Dec 15 17:47:07 GMT 2023
|
PRIMARY | |||
|
11604525
Created by
admin on Fri Dec 15 17:47:07 GMT 2023 , Edited by admin on Fri Dec 15 17:47:07 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
TARGET->INVERSE AGONIST |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |